[Preliminary analysis of intensive treatment of acute lymphoblastic leukemia in children]

Area of Science:

• Pediatric Oncology
• Hematology
• Clinical Immunology

Context:

• Acute lymphoblastic leukemia (ALL) is a significant pediatric malignancy.
• Treatment strategies for ALL aim to maximize remission rates and long-term survival.
• The Memphis group's intensive therapy protocol, including central nervous system radiotherapy, is a recognized treatment modality.

Purpose:

• To evaluate the efficacy of an intensive 3-year maintenance therapy combined with central nervous system radiotherapy for acute lymphoblastic leukemia in children.
• To compare the outcomes of intensive treatment versus more conservative approaches.
• To investigate the role of serum immunoglobulins and infection incidence during treatment.

Summary:

• A study analyzed 31 children with acute lymphoblastic leukemia, with 29 achieving remission after 3 years of intensive maintenance therapy and central nervous system radiotherapy.
• The intensive treatment demonstrated superiority over less intensive methods.
• Therapeutic failures were primarily associated with poor prognostic factors, such as blastic hyperleucocytosis, and the study discussed immunoglobulin levels and infection occurrences.

Impact:

• The findings support the use of intensive treatment protocols for pediatric acute lymphoblastic leukemia, especially in high-risk cases.
• Understanding immunoglobulin behavior and infection risks can help optimize supportive care during leukemia treatment.
• This research contributes to refining treatment strategies for improving outcomes in childhood ALL.